chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; This is a spontaneous report from a non-contactable consumer, the patient. An adult non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 10Apr2021 at 13:45 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 20Mar2021 at 13:45 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, the patient experienced flu like symptoms. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment with Tylenol and Advil. The clinical outcome of the event flu like symptoms was resolved on an unspecified date in Apr2021.  No follow-up attempts are needed. No further information is expected.
LEFT SQ AREA LARGE SWELLING, REDNESS, TENDER, AND WARM TO TOUCH.
This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a male patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included spondylosis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced shoulder pain and pain in arm. On an unknown date, the outcome of the shoulder pain and pain in arm were unknown. It was unknown if the reporter considered the shoulder pain and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient's shoulder and arm hurts terrible after taking SHINGRIX injection. The reporter did not gave consent to follow-up. This case has been linked with US2019000153, reported for same patient.
This spontaneous report was received from a registered nurse refers to an unspecified amount of patients of unknown age and gender. Nurse stated that on an unknown date in 2014 within the past 2 weeks an unspecified amount of patients were vaccinated with a dose of GARDASIL which was improperly stored. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
at the age of 4 months she had her routine shots and the next day she had a fever and was fussy and then vomited with a fever and seemed to be shaking like she was cold so mother took her to the ED (10/14/21)  and by the time she got there she had blotches and was not crying and appeared lethargic and limp and her oxygen level was 73 or 74 with a change in breathing and looked purplish and then with oxygen this color change resolved; they gave her IV fluids and when she was stuck with needles she did not cry; they did an evaluation (not sure what, remembers chest x-ray and urine with catheter); she was diagnosed with some type of "allergic reaction", but was also given an antibiotic; prior to going to the ED she vomiting only once, and was eating however she was taking small, frequent amounts; she had 3 vaccines at age 6 months and was somewhat groggy, wanted to be held, leg red; review of vaccine record indicates the only vaccine she did not have at 6 month old visit was HIB and did not react to others given at age 6 months. Seen by Allergy doctor 10/4/22
Patient lost consciousness post vaccination. She slumped forward.  Immunizing technician moved herself in from of her to prevent her from falling and the patient's whole body weight was resting on the technician. She went in and out of consciousness three times and flailed back in the chair and her eyes rolled back.  One pharmacist called 911 while the other pharmacist stayed with the patient and technician.  We took her blood pressure before the EMTs arrived and it was 106/76 with pulse of 70.
Information has been received from a licensed practical nurse concerning an approximately 18 year old female patient with penicillin allergy who was vaccinated on unspecified dates with a first and second dose of GARDASIL. There was no concomitant medication. The patient experienced a rash under her fingernails the day after receiving the second dose. The patient sought medical attention. She was seen at the hospital on 1-Oct-2008 and a complete blood count with differential was normal. But the symptom persisted. The reporter felt that a rash under her fingernails was related to therapy with GARDASIL. No additional information has been requested.
The following morning, I had extreme dizziness. That persisted for days. There were other symptoms too I had a low-grade fever the 2nd day. It never got over 100.2. I had severe sinus congestion. My head felt stuffy. I felt in a state of confusion. I had extreme postnasal drip and sweating. I also experienced joint aches and nausea and headaches. I just had overall feeling if being unwell. I felt a fullness in my chest in my heart area. I had mucus draining from everywhere. About the 3rd day of feeling this way, I went to an urgent care. A COVID test that was done, came back negative. I was given a medication for inflammation but it was not helpful. The bulk of these symptoms lasted approx. 2 weeks. I am still dealing with dizziness. It is random and will come up out of nowhere. I had a tele visit with my PCP who suggested Mucinex D for help with the nasal drip. This helped but caused some heart palpitations. Also, my heart palpitations increased all while going through this. My heart does not feel healthy. It feels different now, it feels heavy.
This spontaneous report was received from an advanced nurse practitioner via a company representative, referring to a 54 year-old female patient. The patient did not have medical history nor concurrent conditions. The patient's drug reactions/allergies and concomitant medications were not reported. On 13-OCT-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 in her left deltoid, lot # N011867 with expiration date 08-NOV-2018, for prevention of pneumonia (dose and route of administration were not reported). In October 2017, the patient developed cellulitis. It was stated that the patient had a follow up visit with the reporting nurse and an unspecified treatment was given for the adverse event. At the time of reporting, the outcome of the adverse event was unknown. The causality assessment between cellulitis with PNEUMOVAX 23 was not provided. Upon internal review, cellulitis was determined to be a medically significant event.
Adverse Event: Hives, redness and itching around chest  Treatment: Benedryl, Allergy Medicine, Tylenol Outcome: Stopped itchiness
Fever to 103, cough, nasal D/C starting next day. Sx currently improving
Patient received the Pfizer vaccine series on 2/3/21 and 2/24/21.  She asked to receive the Shingles vaccine on 7/24/21 but was administered the Moderna vaccine series on 7/24/21 and 8/28/21.  She did not realize until after the series was complete that it was the Moderna vaccine and not the Shingrix.  She reports no side effects or adverse events other than a sore arm and a small knot at the injection site that resolved on its own in a few days.
a knot at the injection site; redness, and a knot at the injection site; she had pain; redness in face; fever; shivering; headache; fatigue; muscle aches; nausea; loss of appetite,; swelling at the injection site,; This case was reported by a consumer via call center representative and described the occurrence of red face in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 14th August 2020, less than a day after receiving Shingrix, the patient experienced red face, fever, shivering, headache, fatigue, muscle pain, nausea, appetite lost and injection site swelling. In August 2020, the patient experienced injection site nodule, injection site erythema and injection site pain. In August 2020, the outcome of the red face, fever, shivering, headache, fatigue, muscle pain, nausea, appetite lost and injection site swelling were recovered/resolved. On an unknown date, the outcome of the injection site nodule, injection site erythema and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the red face, fever, shivering, headache, fatigue, muscle pain, nausea, appetite lost, injection site swelling, injection site nodule, injection site erythema and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm. The patient reported that after receiving the vaccine on Friday she had pain, redness, and a knot at the injection site and these were all still ongoing at this the time of reporting.  In August 2020, Less than a week after receiving Shingrix,the patient experienced injection site nodule, injection site erythema and injection site pain. The patient reported that on Friday, after receiving the vaccine she had swelling at the injection site, loss of appetite, nausea, muscle aches, fatigue, headache, shivering, fever, and redness in the face that all lasted about 2 days and had since resolved. The reporter consented to follow up
I had a fever the night I got the shot. The next day I felt fatigue and I didn't feel any better and got worse. By Thursday I called my doctor and he prescribed a Z-pack for my throat. By Saturday nothing had changed and I felt worse. It was getting progressively worse each day. Saturday I took a PCR Test and it came back positive. I contacted my doctor's office emergency line Sunday night because I had a fever and feeling worse. They set up Monoclonal Antibodies Infusion within 2 weeks because I am diabetic. The first week I could barely move at one point. I did lose taste and smell later on. I just kept myself hydrated. I had every symptom on the list. My ears were hurting, I felt like I had the flu and thought I had strep throat. After the infusion I was tired for a couple of days but I started to feel better. I steadily improved after that and was able to go back to work.
At first, severe flu-like reactions. Required one day of sick-call.Large swelling and hard bump at location of injection.  Long term, arthritic like symptoms began soon after first injection. Have worsened with each injection, continue to this day.
Right arm red, swollen 1.25 in induration per mo 2.5-1.5 swelling per mo Tx: Tylenol/ Benadryl/Ice
Fever suddenly went to over 105 degrees.  Child had NOT been around anyone sick and was NOT in daycare at the time.  Occurred 13 days after first MMR shot.  After a second dose of MMR at the age of 4 in april 2003, the exact same thing happened 13 days later.  Fever went to over 105.  Was Told it was a "viral illness".
Elevated high red blood cell count, this happen after every COVID vaccine. Then 3 to 4 later it is back to normal range.
Morbilliform rash all over body, starting 12 days after Proquad (MMR-Varivax) injection. No fever, no systemic illness.
itching started 11/29/05 @ 10 am; hives erupted shortly after & became progressively worse; patient called emergency department @ 10:00 pm. Advised to take Benadryl - which is contraindicated for client, because she has glaucoma. Client used topical benadryl throughout the night. Afterward, a fine itchy rash - primarily over torso, neck, shoulders & back.
Pt had large amount of swelling with redness and warmth. Approximately 10 inches by 4 inches-covering most of right upper arm.
This spontaneous report as received from a pharmacist refers to a 61 year old female patient with aspirin and IV iodine allergies. On 09-OCT-2015, the patient was vaccinated with a dose of ZOSTAVAX (route, dose lot # and expiration date were not provided). There was no concomitant medication. On 11-OCT-2015, the patient experienced injection site rash and injection site warmth referred to as a warm "rug burn" like rash around the injection site - about 2.5 inches in diameter. The patient sought medical attention by visiting pharmacy and no treatment was given for the events. No lab diagnostics studies were performed. At the time of this report, the outcome of injection site rash and injection site warmth was reported as not recovered. Additional information has been requested.
Dad describes as a mild itchy rash that began the same night after receiving vaccine. No other new exposures. He was seen in the office today (6 days later) and dad says that the rash has gotten worse. Dad says that the rash is worse with heat.  He took one dose of Benadryl on 9/26/19. He denies fever or any other symptoms. APRN describes the rash as "erythema present to full body, sparing face, palms of hands, and soles of feet - c/w hives to neck and chest,"
My COVID-19 infection started on 03/11/2023 in the morning. I had  a sore throat, headaches, cough, runny nose, and body aches. I did a COVID-19 home test on the same day which was positive. I called my doctor's office and explained my symptoms to my doctor. She then prescribe me Paxlovid for 5 days. I tested negative on 03/29/2023 using a home COVID-19 kit. I still have cough and runny nose as of now.
Presented with intermittent right shoulder pain and ristricted mobility.  Symptoms emerged in early April and worsened through early June.  Diagnosed with adhesive capsulitis of right shoulder in June.  Treated with steroid injection, oral non-steroidal anti-inflammatory and physical therapy.  Pain subsided, mobility improved but not returned to pre-symptomatic level.  Oral anti-inflammatory and physical therapy continuing.
pt recvd vax & devel arthralgias, dyspnea, interstitial lung disease confirmed by lung biopsy; also devel abn serologies & cryoglobulinemia; pt recvd collagen inject into face @ about that time; MD felt assoc w/surface antigen of virus;
2 or 3 minutes after getting  the vaccine, the patient passed out for about 40 seconds. the pharmacist called him couple times then he waked up and started to talk. He was ok after that.
breakthrough infection/infection 6-12 months post-D3; breakthrough infection/infection 6-12 months post-D3; This is a literature report for the following literature source(s):  An adolescent patient received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Adolescent solid organ transplant recipients" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "breakthrough infection/infection 6-12 months post-D3". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: unknown result; Positive.  Follow-up attempts are not needed. No further information is expected.; Sender's Comments: Based on the information currently available, a lack of efficacy with bnt162b2 vaccine in this patient cannot be completely excluded.   ,Linked Report(s) : US-PFIZER INC-PV202300180965 Same article/ drug/event and different patient;
Adv eff med/biol sub NOS on 2014-05-09, clinician comment: local reaction.
Immunization was given on 11/18/2018 at 1833. Donor began feeling nauseous with chills and a fever the next day in the afternoon. Symptoms lasted for approximately a day and a half. Donor has felt fine since resolution of symptoms. The event was reported today. No treatment provided.
Information has been received concerning a 25 year old female medical assistant, who on 26, Jan 2007, during the patient administration of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (lot # 656551/1532F) was inadvertently sprayed on her are with the vaccine. The medical assistant experienced burning on her arm. The arm was flushed with saline. The symptoms resolved on 26, Jan 2007 At the time of the report the medical assistant was considered to be recovered. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
I had my vaccination on 10/24/2022. On 12/11/2022 I started to have fever chills fatigue. I contacted my physician who prescribed Prednisone and Augmentin on 12/16/2022. I was COVID-19 Negative. I am currently 01/23/2023 still having a runny nose lack of energy brain fog and fatigue on 01/23/2023.
Information for the Merck Pregnancy registry for GARDASIL vaccine (yeast) has been received from a 20 year old female with urinary tract infection and not known allergies, who on 26-JUN-2008 was vaccinated with the second dose of GARDASIL vaccine (yeast). Concomitant therapy included medications for urinary tract infection. The patient reported that she did not know that she was pregnant at the time of administration of the vaccine. On 29-JUN-2008, three days after vaccination, the patient experienced "itching all over". Subsequently, the patient recovered from the itching. Laboratory studies were not performed. At the time of reporting, the patient was 2 months and 2 weeks pregnant. Additional information has been requested.
3 1/2" x 3 1/2" circular local rxn;redness, warmth & edges sl indurated;no pain-lt deltoid;
Swollen lymph node on armpit at the side of injection; Slight stuffed nose; Chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 12:15 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 24Apr2021, at 02:00, the patient experienced chills and headache, slight stuffed nose, swollen lymph node on armpit at the side of injection. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills and headache, slight stuffed nose, swollen lymph node on armpit at the side of injection was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Migraine with aura without headache (diagnosed by medical professional). Visual disturbance for about 20 minutes. Slightly elevated blood pressure.
dx w/GBS;complete paralysis of legs;severely weakened upper body, torso, arms, hands;no ventilator needed;tx w/Immunoglobulin therapy (5 days);physical therapy (2mo) & pain killers for extreme back pain;regained nl abilities p/ 2.5 mo
Fever; Cough; Headache; Cold; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), COUGH (Cough), HEADACHE (Headache) and NASOPHARYNGITIS (Cold) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included LOSARTAN, TAMSULOSIN, HCTZ, B & FOLIC, NICOTINIC ACID (B3 NIACIN) and OMEPRAZOLE for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PYREXIA (Fever), COUGH (Cough), HEADACHE (Headache) and NASOPHARYNGITIS (Cold). At the time of the report, PYREXIA (Fever), COUGH (Cough), HEADACHE (Headache) and NASOPHARYNGITIS (Cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient has not provided with treatment
Progress pain in nerve root encompassing left breast, left axilla, and along left arm including thumb and thumb side of index finger.  Pain was a burning and crawling sensation that radiated from sternum into axilla; exacerbated by wind or light touch.  Pain continues to this day.  My physician said that symptoms consistent with shingles, but there was never a rash.  Diagnosis: Post Herpetic Neuropathy from Zoster vaccine.
Itchy arm/throat, stinging eyes. BP 147/80 (pulse 96), O2 sat 99%. Benadryl 25 mg PO x 2. Stable.
90 min - 2 hrs after receiving vaccination patient developed severe nausea, near vomiting low back pain and generalized body aches. Severe pain in (L) arm with difficulty using arm. Intensity of symptoms gradually declined over next 24 hours with back pain persisting into 36 hour. Some nausea on Day 2. Symptoms completely resolved w/in 48 hours.
This spontaneous report as received from a physician assistant via company representative refers to 2 patients of unknown age and gender. No information about medical history, concurrent conditions was reported for the patients. On an unknown date the 2 doses of improperly stored MMR II which were not supported were administered to 2 unspecified patients. No adverse effects reported. The outcome of reported events is unknown. No product quality complaint was involved. This case is linked to the case 1503USA013941 via same reporter link. Additional information has been requested.
rigors; fevers; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): LRN4467433.  A 44 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "NSAID allergy" (unspecified if ongoing), notes: Patient concurrent condition included: NSAID allergy; "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "rigors"; PYREXIA (non-serious), outcome "unknown", described as "fevers".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I previously had the COVID virus in December of 2020. I drew antibody titers in May and had high level of antibodies (I believe the result was 186 ng/dL).  I received the vaccine on Tuesday 8/31 at 1:30 pm. By that evening I felt like a truck ran over my whole body, the joint pain was very intense. (Immunologic storm) It started getting better by the afternoon that next day, sore arm for 3 days. That next day is when I first start leaking amniotic fluid, more noticeable Thursday and definitely larger gushes by Friday. I ended up in preterm labor and gave birth to my baby at 34+4 weeks. My original due date was 10/15/2021. Baby?s birth weight 4 lb 7 oz
Patient received smallpox vaccine 03/05/2003 and went overseas.  On 08/18 patient started to have pain/tingle in left upper arm.  Scheduled appointment 09/20/2003 with follow up MD.  Surgeon told patient probably pulled/strained arm washing car, not smallpox vaccine related.  Patient then stated has had numb/tingles in right arm-prominentely local related in carpal tunnel.